Thermo Fisher (TMO) Paying $925M For Transplant Diagnostics Co. iStockAnalyst George Ayoub, co-founder and chief executive officer of One Lambda said the transaction "will increase the use of human leukocyte antigen (HLA) typing and antibody detection to accelerate growth and improve the success rate of transplantation." ... |
